Low dose amiodarone reduces tumor growth and angiogenesis

Amiodarone is an anti-arrhythmic drug that was approved by the US Food and Drug Administration (FDA) in 1985. Pre-clinical studies suggest that Amiodarone induces cytotoxicity in several types of cancer cells, thus making it a potential candidate for use as an anti-cancer treatment. However, it is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Eliana, Fluksman, Arnon, Zemmour, Chalom, Tischenko, Katerina, Karsch-Bluman, Adi, Brill-Karniely, Yifat, Birsner, Amy E., D’Amato, Robert J., Benny, Ofra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582908/
https://www.ncbi.nlm.nih.gov/pubmed/33093573
http://dx.doi.org/10.1038/s41598-020-75142-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582908/
https://www.ncbi.nlm.nih.gov/pubmed/33093573
http://dx.doi.org/10.1038/s41598-020-75142-1

Ejemplares similares